$1.52 Billion is the total value of Deep Track Capital, LP's 51 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 28.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $116,512,000 | +45.9% | 3,646,690 | +58.2% | 7.66% | +49.6% |
| NVCR | Buy | NOVOCURE LTD | $93,220,000 | +12.5% | 1,341,300 | +34.1% | 6.13% | +15.3% |
| TVTX | Buy | TRAVERE THERAPEUTICS INC | $86,760,000 | +7.4% | 3,580,700 | +14.2% | 5.70% | +10.1% |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $78,005,000 | -3.1% | 500,000 | -3.3% | 5.13% | -0.7% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INCcall | $72,910,000 | – | 499,900 | +100.0% | 4.79% | – |
| KURA | Buy | KURA ONCOLOGY INC | $67,784,000 | +23.5% | 3,697,969 | +8.4% | 4.46% | +26.7% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $64,780,000 | -16.0% | 905,000 | +15.1% | 4.26% | -13.9% |
| KDNY | Buy | CHINOOK THERAPEUTICS INC | $59,993,000 | +22.2% | 3,430,110 | +14.3% | 3.94% | +25.3% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $54,227,000 | – | 654,365 | +100.0% | 3.56% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $50,006,000 | -35.5% | 2,018,005 | +0.9% | 3.29% | -33.9% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $48,662,000 | -40.2% | 2,900,000 | +56.3% | 3.20% | -38.8% |
| BEAM | Buy | BEAM THERAPEUTICS INC | $48,388,000 | +10.6% | 1,250,000 | +63.7% | 3.18% | +13.4% |
| ISEE | IVERIC BIO INC | $43,290,000 | -42.8% | 4,500,000 | 0.0% | 2.85% | -41.4% | |
| AGEN | Buy | AGENUS INC | $43,148,000 | +25.3% | 22,241,417 | +58.9% | 2.84% | +28.4% |
| ESPR | ESPERION THERAPEUTICS INC NE | $38,160,000 | +37.1% | 6,000,000 | 0.0% | 2.51% | +40.5% | |
| RPTX | Buy | REPARE THERAPEUTICS INC | $37,880,000 | -0.1% | 2,707,662 | +1.6% | 2.49% | +2.3% |
| NUVB | Buy | NUVATION BIO INC | $37,167,000 | +511.5% | 11,471,281 | +892.8% | 2.44% | +526.4% |
| IMVT | Buy | IMMUNOVANT INC | $36,875,000 | -7.4% | 9,455,000 | +30.9% | 2.42% | -5.1% |
| NKTX | Buy | NKARTA INC | $34,679,000 | +44.2% | 2,814,844 | +33.2% | 2.28% | +47.8% |
| NRIX | New | NURIX THERAPEUTICS INC | $30,866,000 | – | 2,436,164 | +100.0% | 2.03% | – |
| FMTX | Buy | FORMA THERAPEUTICS HLDGS INC | $27,905,000 | +80.8% | 4,050,000 | +144.0% | 1.83% | +85.3% |
| TCDA | Buy | TRICIDA INC | $26,447,000 | +21.3% | 2,732,117 | +3.0% | 1.74% | +24.4% |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $24,420,000 | – | 1,733,130 | +100.0% | 1.60% | – |
| DYN | DYNE THERAPEUTICS INC | $24,045,000 | -28.7% | 3,500,000 | 0.0% | 1.58% | -26.9% | |
| FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $21,917,000 | -40.8% | 3,140,000 | +28.3% | 1.44% | -39.3% |
| KROS | Sell | KEROS THERAPEUTICS INC | $20,433,000 | -72.8% | 739,528 | -46.4% | 1.34% | -72.1% |
| CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $19,638,000 | -42.0% | 1,053,000 | -31.7% | 1.29% | -40.5% |
| KALV | Buy | KALVISTA PHARMACEUTICALS INC | $17,948,000 | -29.6% | 1,824,000 | +5.4% | 1.18% | -27.8% |
| Sell | DICE THERAPEUTICS INC | $16,186,000 | -32.3% | 1,042,900 | -16.6% | 1.06% | -30.6% | |
| INZY | New | INOZYME PHARMA INC | $15,503,000 | – | 3,250,000 | +100.0% | 1.02% | – |
| SDGR | New | SCHRODINGER INC | $14,842,000 | – | 562,000 | +100.0% | 0.98% | – |
| ABOS | Buy | ACUMEN PHARMACEUTICALS INC | $14,570,000 | +43.4% | 3,100,000 | +19.3% | 0.96% | +46.9% |
| ANAB | Buy | ANAPTYSBIO INC | $13,653,000 | -1.2% | 672,569 | +20.4% | 0.90% | +1.2% |
| VRDN | VIRIDIAN THERAPEUTICS INC | $13,540,000 | -37.4% | 1,170,290 | 0.0% | 0.89% | -35.9% | |
| ACET | New | ADICET BIO INC | $13,024,000 | – | 892,028 | +100.0% | 0.86% | – |
| JNCE | JOUNCE THERAPEUTICS INC | $12,907,000 | -55.4% | 4,259,653 | 0.0% | 0.85% | -54.3% | |
| SLN | SILENCE THERAPEUTICS PLCads | $11,276,000 | -37.6% | 951,580 | 0.0% | 0.74% | -36.1% | |
| RLMD | Buy | RELMADA THERAPEUTICS INC | $9,495,000 | +244.5% | 500,000 | +389.6% | 0.62% | +252.5% |
| HOOK | HOOKIPA PHARMA INC | $8,209,000 | -28.5% | 5,035,998 | 0.0% | 0.54% | -26.6% | |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $7,767,000 | -33.4% | 924,641 | -0.2% | 0.51% | -31.7% |
| MGTA | MAGENTA THERAPEUTICS INC | $6,431,000 | -58.6% | 5,359,000 | 0.0% | 0.42% | -57.6% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $6,300,000 | +1.9% | 3,000,000 | 0.0% | 0.41% | +4.5% | |
| SAGE | Sell | SAGE THERAPEUTICS INC | $5,549,000 | -75.2% | 171,800 | -74.5% | 0.36% | -74.5% |
| PASG | Sell | PASSAGE BIO INC | $5,475,000 | -47.7% | 2,320,000 | -31.3% | 0.36% | -46.3% |
| GHRS | GH RESEARCH PLCordinary shares | $4,984,000 | -45.4% | 499,400 | 0.0% | 0.33% | -44.0% | |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $4,900,000 | -68.1% | 1,000,000 | +53.8% | 0.32% | -67.3% |
| GRTS | Sell | GRITSTONE BIO INC | $4,162,000 | -66.2% | 1,720,000 | -42.4% | 0.27% | -65.3% |
| Sell | TENAYA THERAPEUTICS INC | $2,724,000 | -57.7% | 483,836 | -11.5% | 0.18% | -56.7% | |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INCput | $2,061,000 | -41.3% | 260,500 | +75.7% | 0.14% | -40.0% |
| LIFE | Sell | ATYR PHARMA INC | $823,000 | -85.0% | 290,844 | -71.7% | 0.05% | -84.7% |
| Sell | VIGIL NEUROSCIENCE INC | $796,000 | -70.9% | 308,393 | -20.8% | 0.05% | -70.3% | |
| RFL | Exit | RAFAEL HLDGS INC | $0 | – | -104,156 | -100.0% | -0.02% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -382,559 | -100.0% | -0.10% | – |
| VERV | Exit | VERVE THERAPEUTICS INC | $0 | – | -102,342 | -100.0% | -0.15% | – |
| NKTR | Exit | NEKTAR THERAPEUTICSput | $0 | – | -500,000 | -100.0% | -0.17% | – |
| NKTR | Exit | NEKTAR THERAPEUTICScall | $0 | – | -1,000,000 | -100.0% | -0.35% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -245,000 | -100.0% | -0.59% | – |
| ENTA | Exit | ENANTA PHARMACEUTICALS INC | $0 | – | -198,730 | -100.0% | -0.91% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -463,663 | -100.0% | -4.86% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | 8 | Q3 2023 | 7.2% |
| TRAVERE THERAPEUTICS INC | 8 | Q3 2023 | 5.7% |
| IMMUNOVANT INC | 8 | Q3 2023 | 7.2% |
| BICYCLE THERAPEUTICS PLC | 8 | Q3 2023 | 5.2% |
| BEAM THERAPEUTICS INC | 8 | Q3 2023 | 3.9% |
| 4D MOLECULAR THERAPEUTICS IN | 8 | Q3 2023 | 2.9% |
| REPARE THERAPEUTICS INC | 8 | Q3 2023 | 3.1% |
| VIRIDIAN THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| DYNE THERAPEUTICS INC | 8 | Q3 2023 | 2.2% |
| SILENCE THERAPEUTICS PLC | 8 | Q3 2023 | 1.6% |
View Deep Track Capital, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Orchard Therapeutics plc | March 20, 2023 | 19,125,150 | 10.0% |
| ARDELYX, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2023 | 1,833,437 | 3.8% |
| Aurinia Pharmaceuticals Inc. | February 14, 2023 | 324,238 | 0.2% |
| CHINOOK THERAPEUTICS, INC. | February 14, 2023 | 3,000,000 | 4.7% |
| Forma Therapeutics Holdings, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Global Blood Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| HOOKIPA Pharma Inc. | February 14, 2023 | 1,240,369 | 2.4% |
| KalVista Pharmaceuticals, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Keros Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View Deep Track Capital, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-12 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-22 |
| SC 13G | 2024-03-15 |
| 3 | 2024-03-14 |
| SC 13G | 2024-03-08 |
| SC 13G | 2024-02-23 |
| 13F-HR | 2024-02-14 |
View Deep Track Capital, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.